Ligand Pharmaceuticals reported $34.99M in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Anika Therapeutics ANIK:US $ 1.25M 7.88M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
Arrowhead Research ARWR:US $ -63.37M 33.45M
Baxter International BAX:US $ 608M 107M
Bristol Myers Squibb BMY:US $ 5289M 67M
Clovis Oncology CLVS:US $ -67.4M 0.95M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Enanta Pharmaceuticals ENTA:US $ -33.39M 0.01M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Immunogen IMGN:US $ -37.34M 6.6M
Insmed INSM:US $ -115292000 1.41M
Intrexon XON:US $ -29.88M 9.76M
IONIS PHARMACEUT IONS:US $ -84M 3M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Macrogenics MGNX:US $ -52.89M 12.95M
Rigel Pharmaceuticals RIGL:US $ -21.09M 6.3M
Sangamo Biosciences SGMO:US $ -47.6M 0.45M
Spectrum Pharmaceuticals SPPI:US $ -33.07M 16.85M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
Veracyte VCYT:US $ -15.48M 24.67M